TapewireFind a company

organization · Reporting owner

Morningside Venture Investments Ltd

Disclosed activity across 6 companies

Tapewire entity
26252
SEC CIK
0001543112

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Apellis Pharmaceuticals, Inc.APLS · Entity 4732210% ownerNovember 18, 2021November 18, 2021
Apnimed, Inc.APMD · Entity 491010% ownerAugust 03, 2026August 05, 2026
GreenLight Biosciences Holdings, PBCGRNA · Entity 11107510% ownerJuly 24, 2023July 25, 2023
Kezar Life Sciences, Inc.KZR · Entity 1211110% ownerAugust 15, 2023August 17, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Apellis Pharmaceuticals, Inc.

Report date November 18, 2021 · Filed November 18, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect12,806,342 Reported balance After 2021-11-18 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2021-11-18 · Purchase · Acquired 250,000 · Balance 12,806,342

F1: Frances Anne Elizabeth Richard, Cheung Ka Ho, Jill Marie Franklin and Peter Stuart Allenby Edwards, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Filing footnotes · ownership attribution and instrument terms

F1: Frances Anne Elizabeth Richard, Cheung Ka Ho, Jill Marie Franklin and Peter Stuart Allenby Edwards, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Apnimed, Inc.

Report date August 03, 2026 · Filed August 05, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect0 Last balance in matching sequence After 2026-08-03 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 1 · 2026-08-03 · Conversion · Acquired 6,840,213 · Balance 6,840,213

F1: Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date.

F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

Row 2 · 2026-08-03 · Other · Disposed 6,840,213 · Balance 0

F3: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").

F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

Common StockSEC Table I · non-derivativeDirect7,152,713 Last balance in matching sequence After 2026-08-03 transaction · row 4 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 3 · 2026-08-03 · Other · Acquired 6,840,213 · Balance 6,840,213

F3: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").

F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

Row 4 · 2026-08-03 · Purchase · Acquired 312,500 · Balance 7,152,713

F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

Class A Common StockSEC Table I · non-derivativeIndirectBy MVIL, LLC0 Last balance in matching sequence After 2026-08-03 transaction · row 6 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 5 · 2026-08-03 · Conversion · Acquired 75,624 · Balance 75,624

F4: The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40.

F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

F6: Represents securities held by MVIL, LLC.

Row 6 · 2026-08-03 · Other · Disposed 75,624 · Balance 0

F3: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").

F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

F6: Represents securities held by MVIL, LLC.

Common StockSEC Table I · non-derivativeIndirectBy MVIL, LLC75,624 Reported balance After 2026-08-03 transaction · row 7 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 7 · 2026-08-03 · Other · Acquired 75,624 · Balance 75,624

F3: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").

F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

F6: Represents securities held by MVIL, LLC.

Convertible Preferred StockSEC Table II · derivative / convertible securityDirect0 Reported balance After 2026-08-03 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2026-08-03 · Conversion · Disposed 9,227,454 · Balance 0

F1: Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date.

F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

Convertible Promissory NoteSEC Table II · derivative / convertible security · Conversion / exercise price $14.40IndirectBy MVIL, LLC0 Reported balance After 2026-08-03 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2026-08-03 · Conversion · Disposed 1,088,986.3 · Balance 0

F4: The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40.

F5: The Notes were scheduled to mature on September 17, 2027, but converted automatically upon the closing of the IPO on August 3, 2026, prior to the maturity date.

F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

F6: Represents securities held by MVIL, LLC.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date.

F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

F3: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").

F4: The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40.

F5: The Notes were scheduled to mature on September 17, 2027, but converted automatically upon the closing of the IPO on August 3, 2026, prior to the maturity date.

F6: Represents securities held by MVIL, LLC.

GreenLight Biosciences Holdings, PBC

Report date July 24, 2023 · Filed July 25, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2023-07-24 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2023-07-24 · Other · Disposed 16,919,155 · Balance 0

F1: Consists of 15,919,155 shares of common stock held directly by Morningside Venture Investments Limited and 1,000,000 shares of common stock held by MVIL, LLC, its wholly owned subsidiary.

F2: In connection with the merger of the Issuer with a wholly owned subsidiary of SW ParentCo, Inc. ("Parent"), the Reporting Persons entered into a Contribution and Exchange Agreement pursuant to which, on July 21, 2023, they contributed all of their shares of the Issuer's common stock to Parent in exchange for shares of preferred stock of Parent.

Filing footnotes · ownership attribution and instrument terms

F1: Consists of 15,919,155 shares of common stock held directly by Morningside Venture Investments Limited and 1,000,000 shares of common stock held by MVIL, LLC, its wholly owned subsidiary.

F2: In connection with the merger of the Issuer with a wholly owned subsidiary of SW ParentCo, Inc. ("Parent"), the Reporting Persons entered into a Contribution and Exchange Agreement pursuant to which, on July 21, 2023, they contributed all of their shares of the Issuer's common stock to Parent in exchange for shares of preferred stock of Parent.

Kezar Life Sciences, Inc.

Report date August 15, 2023 · Filed August 17, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect1,947,993 Reported balance After 2023-08-15 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2023-08-15 · Gift · Disposed 3,500,000 · Balance 1,947,993

F1: Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares.

F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares.

F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Amylyx Pharmaceuticals, Inc.

Report date August 15, 2023 · Filed August 17, 2023

Section 16 reporting ended · disclosed 2023-08-17. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect4,997,302 Reported balance After 2023-08-15 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2023-08-15 · Gift · Disposed 2,000,000 · Balance 4,997,302

F1: Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares.

F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares.

F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL.

Liquidia Technologies Inc

Report date July 30, 2018 · Filed August 01, 2018

Section 16 reporting ended · disclosed 2018-08-01. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect552,728 Last balance in matching sequence After 2018-07-30 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 1 · 2018-07-30 · Conversion · Acquired 442,819 · Balance 442,819

F1: The Series C preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.1295-for-1 basis immediately prior to the closing of the Issuer's initial public offering.

F4: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Row 2 · 2018-07-30 · Conversion · Acquired 109,909 · Balance 552,728

F2: The Series D preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.0594-for-1 basis immediately prior to the closing of the Issuer's initial public offering.

F4: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Series C Preferred StockSEC Table II · derivative / convertible securityDirect0 Reported balance After 2018-07-30 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2018-07-30 · Conversion · Disposed 3,420,516 · Balance 0

F1: The Series C preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.1295-for-1 basis immediately prior to the closing of the Issuer's initial public offering.

F4: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Series D Preferred StockSEC Table II · derivative / convertible securityDirect0 Reported balance After 2018-07-30 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2018-07-30 · Conversion · Disposed 1,849,490 · Balance 0

F2: The Series D preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.0594-for-1 basis immediately prior to the closing of the Issuer's initial public offering.

F4: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Warrant to purchase Series D Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.01 · Expires 2026-12-31Direct0 Reported balance After 2018-07-30 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2018-07-30 · Other · Disposed 319,664 · Balance 0

F3: Immediately prior to the closing of the Issuer's initial public offering and without payment of further consideration, the Warrants to purchase Series D Preferred Stock automatically became exercisable to purchase the Issuer's common stock. The transaction is listed solely for the purpose of reporting the change of the title and amount of securities underlying the warrant.

F4: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Warrant to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.01 · Expires 2026-12-31Direct18,996 Reported balance After 2018-07-30 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2018-07-30 · Other · Acquired 18,996 · Balance 18,996

F3: Immediately prior to the closing of the Issuer's initial public offering and without payment of further consideration, the Warrants to purchase Series D Preferred Stock automatically became exercisable to purchase the Issuer's common stock. The transaction is listed solely for the purpose of reporting the change of the title and amount of securities underlying the warrant.

F4: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Filing footnotes · ownership attribution and instrument terms

F1: The Series C preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.1295-for-1 basis immediately prior to the closing of the Issuer's initial public offering.

F2: The Series D preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.0594-for-1 basis immediately prior to the closing of the Issuer's initial public offering.

F3: Immediately prior to the closing of the Issuer's initial public offering and without payment of further consideration, the Warrants to purchase Series D Preferred Stock automatically became exercisable to purchase the Issuer's common stock. The transaction is listed solely for the purpose of reporting the change of the title and amount of securities underlying the warrant.

F4: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 03, 2026 Filed Aug 5, 2026 20:18 UTC Apnimed, Inc. APMD · Entity 4910 ConversionConvertible Promissory Note · Derivative 1,088,986.3 $0.00 Strike: $14.40 $0.00
Disclosure

SEC source: 0000905148-26-003483 · form4.xml · derivative · entry 9

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By MVIL, LLC

Disclosed balance after: 0

Underlying: Class A Common Stock · 75,624 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40.

F4 · shares: The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40.

F4 · derivative.exercise_date: The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40.

F5 · derivative.expiration_date: The Notes were scheduled to mature on September 17, 2027, but converted automatically upon the closing of the IPO on August 3, 2026, prior to the maturity date.

F2 · ownership.nature: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

F6 · ownership.nature: Represents securities held by MVIL, LLC.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:18 UTC Apnimed, Inc. APMD · Entity 4910 ConversionConvertible Preferred Stock · Derivative 9,227,454 $0.00 $0.00
Disclosure

SEC source: 0000905148-26-003483 · form4.xml · derivative · entry 8

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 6,840,213 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date.

F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:18 UTC Apnimed, Inc. APMD · Entity 4910 OtherCommon Stock 75,624 Not disclosed Not disclosed
Disclosure

SEC source: 0000905148-26-003483 · form4.xml · nonDerivative · entry 7

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By MVIL, LLC

Disclosed balance after: 75,624

F3 · kind: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").

F3 · price: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").

F2 · ownership.nature: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

F6 · ownership.nature: Represents securities held by MVIL, LLC.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:18 UTC Apnimed, Inc. APMD · Entity 4910 OtherClass A Common Stock 75,624 Not disclosed Not disclosed
Disclosure

SEC source: 0000905148-26-003483 · form4.xml · nonDerivative · entry 6

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By MVIL, LLC

Disclosed balance after: 0

F3 · kind: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").

F3 · price: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").

F2 · ownership.nature: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

F6 · ownership.nature: Represents securities held by MVIL, LLC.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:18 UTC Apnimed, Inc. APMD · Entity 4910 ConversionClass A Common Stock 75,624 $14.40 $1,088,985.60
Disclosure

SEC source: 0000905148-26-003483 · form4.xml · nonDerivative · entry 5

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By MVIL, LLC

Disclosed balance after: 75,624

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40.

F2 · ownership.nature: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

F6 · ownership.nature: Represents securities held by MVIL, LLC.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:18 UTC Apnimed, Inc. APMD · Entity 4910 PurchaseCommon Stock 312,500 $16.00 $5,000,000.00
Disclosure

SEC source: 0000905148-26-003483 · form4.xml · nonDerivative · entry 4

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,152,713

F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:18 UTC Apnimed, Inc. APMD · Entity 4910 OtherCommon Stock 6,840,213 Not disclosed Not disclosed
Disclosure

SEC source: 0000905148-26-003483 · form4.xml · nonDerivative · entry 3

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,840,213

F3 · kind: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").

F3 · price: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").

F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:18 UTC Apnimed, Inc. APMD · Entity 4910 OtherClass A Common Stock 6,840,213 Not disclosed Not disclosed
Disclosure

SEC source: 0000905148-26-003483 · form4.xml · nonDerivative · entry 2

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F3 · kind: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").

F3 · price: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").

F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:18 UTC Apnimed, Inc. APMD · Entity 4910 ConversionClass A Common Stock 6,840,213 Not disclosed Not disclosed
Disclosure

SEC source: 0000905148-26-003483 · form4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,840,213

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date.

F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 21:34 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 GiftCommon Stock 2,000,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-018211 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,997,302

F1 · shares: Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares.

F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 23:08 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 GiftCommon Stock 3,500,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-043301 · ownership.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,947,993

F1 · shares: Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares.

F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL.

Read SEC document
July 24, 2023 Filed Jul 25, 2023 20:01 UTC GreenLight Biosciences Holdings, PBC GRNA · Entity 111075 OtherCommon Stock 16,919,155 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-23-034397 · ownership.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Consists of 15,919,155 shares of common stock held directly by Morningside Venture Investments Limited and 1,000,000 shares of common stock held by MVIL, LLC, its wholly owned subsidiary.

F2 · price: In connection with the merger of the Issuer with a wholly owned subsidiary of SW ParentCo, Inc. ("Parent"), the Reporting Persons entered into a Contribution and Exchange Agreement pursuant to which, on July 21, 2023, they contributed all of their shares of the Issuer's common stock to Parent in exchange for shares of preferred stock of Parent.

F2 · ownership.direct: In connection with the merger of the Issuer with a wholly owned subsidiary of SW ParentCo, Inc. ("Parent"), the Reporting Persons entered into a Contribution and Exchange Agreement pursuant to which, on July 21, 2023, they contributed all of their shares of the Issuer's common stock to Parent in exchange for shares of preferred stock of Parent.

Read SEC document
March 29, 2023 Filed Mar 31, 2023 20:05 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 29,048 $30.45 $884,511.60
Disclosure

SEC source: 0000899243-23-010078 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,997,302

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.09 to $31.06, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
March 28, 2023 Filed Mar 29, 2023 20:05 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 100,000 $30.37 $3,037,000.00
Disclosure

SEC source: 0000899243-23-009972 · doc4.xml · nonDerivative · entry 3

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,026,350

F3 · price: (The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.06 to $30.86, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F4 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
March 27, 2023 Filed Mar 29, 2023 20:05 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 28,000 $30.80 $862,400.00
Disclosure

SEC source: 0000899243-23-009972 · doc4.xml · nonDerivative · entry 2

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,126,350

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.74 to $30.88, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F4 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
March 27, 2023 Filed Mar 29, 2023 20:05 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 32,964 $30.25 $997,161.00
Disclosure

SEC source: 0000899243-23-009972 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,154,350

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.67 to $30.65, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F4 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 20:05 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 28,807 $32.17 $926,721.19
Disclosure

SEC source: 0000899243-23-009506 · doc4.xml · nonDerivative · entry 2

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,187,314

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.005 to $32.38, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 20:05 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 34,641 $31.69 $1,097,773.29
Disclosure

SEC source: 0000899243-23-009506 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,216,121

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $32.00, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
March 16, 2023 Filed Mar 17, 2023 20:05 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 9,122 $32.55 $296,921.10
Disclosure

SEC source: 0000899243-23-008858 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,250,762

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.50 to $32.93, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
March 15, 2023 Filed Mar 16, 2023 20:11 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 41,066 $33.68 $1,383,102.88
Disclosure

SEC source: 0000899243-23-008733 · doc4.xml · nonDerivative · entry 3

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,259,884

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.505 to $34.460, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F4 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
March 15, 2023 Filed Mar 16, 2023 20:11 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 108,934 $33.12 $3,607,894.08
Disclosure

SEC source: 0000899243-23-008733 · doc4.xml · nonDerivative · entry 2

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,300,950

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.5 to $33.5, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F4 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
March 14, 2023 Filed Mar 16, 2023 20:11 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 70,714 $34.54 $2,442,461.56
Disclosure

SEC source: 0000899243-23-008733 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,409,884

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.50 to $34.88, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F4 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 14:10 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 50,000 $33.75 $1,687,500.00
Disclosure

SEC source: 0000899243-23-007120 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,480,598

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.38 to $34.04, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
February 23, 2023 Filed Feb 24, 2023 21:13 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 1,111 $36.24 $40,262.64
Disclosure

SEC source: 0000899243-23-006123 · doc4.xml · nonDerivative · entry 4

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,580,598

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.15 to $36.36, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F5 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
February 23, 2023 Filed Feb 24, 2023 21:13 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 48,889 $35.55 $1,738,003.95
Disclosure

SEC source: 0000899243-23-006123 · doc4.xml · nonDerivative · entry 3

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,581,709

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.14 to $36.14, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F5 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
February 22, 2023 Filed Feb 24, 2023 21:13 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 10,084 $36.34 $366,452.56
Disclosure

SEC source: 0000899243-23-006123 · doc4.xml · nonDerivative · entry 2

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,630,598

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.21 to $36.52, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F5 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
February 22, 2023 Filed Feb 24, 2023 21:13 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 39,916 $35.91 $1,433,383.56
Disclosure

SEC source: 0000899243-23-006123 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,640,682

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.20, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F5 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
February 22, 2023 Filed Feb 28, 2023 21:06 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 2,112 $35.34 $74,638.08
Disclosure

SEC source: 0000899243-23-006394 · doc4.xml · nonDerivative · entry 2

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,530,598

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.28 to $35.45, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
February 22, 2023 Filed Feb 28, 2023 21:06 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 SaleCommon Stock 47,888 $34.70 $1,661,713.60
Disclosure

SEC source: 0000899243-23-006394 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,532,710

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.25 to $35.25, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
February 06, 2023 Filed Feb 7, 2023 21:11 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 40,000 $6.88 $275,320.00
Disclosure

SEC source: 0000899243-23-004187 · doc4.xml · nonDerivative · entry 2

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,447,993

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.82 to $7.08, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
February 03, 2023 Filed Feb 7, 2023 21:11 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 25,000 $7.15 $178,650.00
Disclosure

SEC source: 0000899243-23-004187 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,487,993

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.065 to $7.44, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
February 02, 2023 Filed Feb 3, 2023 21:32 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 50,000 $7.19 $359,500.00
Disclosure

SEC source: 0000899243-23-003869 · doc4.xml · nonDerivative · entry 2

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,512,993

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.93 to $7.32, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 21:32 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 40,000 $6.95 $278,000.00
Disclosure

SEC source: 0000899243-23-003869 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,562,993

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.805 to $7.19, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
January 31, 2023 Filed Feb 1, 2023 21:07 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 30,000 $7.08 $212,400.00
Disclosure

SEC source: 0000899243-23-003120 · doc4.xml · nonDerivative · entry 2

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,602,993

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.92 to $7.18, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
January 30, 2023 Filed Feb 1, 2023 21:07 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 30,000 $6.91 $207,300.00
Disclosure

SEC source: 0000899243-23-003120 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,632,993

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.69 to $7.03, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
January 25, 2023 Filed Jan 27, 2023 21:17 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 50,000 $6.85 $342,500.00
Disclosure

SEC source: 0000899243-23-002854 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,662,993

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.77 to $6.96, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
January 24, 2023 Filed Jan 25, 2023 23:17 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 80,000 $6.98 $558,400.00
Disclosure

SEC source: 0000899243-23-002677 · doc4.xml · nonDerivative · entry 2

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,712,993

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $7.095, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
January 23, 2023 Filed Jan 25, 2023 23:17 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 80,000 $6.81 $544,800.00
Disclosure

SEC source: 0000899243-23-002677 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,792,993

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.29 to $7.02, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
January 17, 2023 Filed Jan 19, 2023 21:12 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 6,114 $6.79 $41,514.06
Disclosure

SEC source: 0000899243-23-002157 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,872,993

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.44 to $6.84, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 21:28 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 1,971 $7.15 $14,092.65
Disclosure

SEC source: 0000899243-23-001846 · doc4.xml · nonDerivative · entry 2

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,879,107

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.61 to $7.37, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
January 12, 2023 Filed Jan 17, 2023 21:28 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 5,000 $6.77 $33,850.00
Disclosure

SEC source: 0000899243-23-001846 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,881,078

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.985 to $6.92, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:08 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 3,000 $6.89 $20,670.00
Disclosure

SEC source: 0000899243-23-001293 · doc4.xml · nonDerivative · entry 2

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,886,078

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.68 to $7.12, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F1 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
January 05, 2023 Filed Jan 9, 2023 21:08 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 12,162 $6.97 $84,769.14
Disclosure

SEC source: 0000899243-23-001293 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,889,078

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.89 to $7.17, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F1 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
January 04, 2023 Filed Jan 5, 2023 21:10 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 30,000 $7.17 $215,100.00
Disclosure

SEC source: 0000899243-23-000979 · doc4.xml · nonDerivative · entry 3

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,901,240

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.91 to $7.28, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F1 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:10 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 500 $7.10 $3,550.00
Disclosure

SEC source: 0000899243-23-000979 · doc4.xml · nonDerivative · entry 2

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,931,240

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.34, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F1 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
December 29, 2022 Filed Jan 5, 2023 21:10 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 25,000 $7.10 $177,500.00
Disclosure

SEC source: 0000899243-23-000979 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,931,740

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.58 to $7.38, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F1 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
October 18, 2022 Filed Jan 11, 2023 21:09 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 GiftCommon Stock 120,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-001583 · doc5.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,931,740

Read SEC document
October 04, 2022 Filed Oct 5, 2022 20:05 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 3,612 $8.82 $31,857.48
Disclosure

SEC source: 0000899243-22-032974 · doc4.xml · nonDerivative · entry 2

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,076,740

F1 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 20:05 UTC Kezar Life Sciences, Inc. KZR · Entity 12111 SaleCommon Stock 28,700 $8.78 $251,957.30
Disclosure

SEC source: 0000899243-22-032974 · doc4.xml · nonDerivative · entry 1

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,080,352

F1 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.

Read SEC document
September 23, 2022 Filed Jan 11, 2023 21:07 UTC Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 GiftCommon Stock 833,333 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-001580 · doc5.xml · nonDerivative · entry 4

Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,680,598

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.